Ikarian Capital »

Quoin Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of Quoin Pharmaceuticals (QNRX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Quoin Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Quoin Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quoin Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.1M 212k 14.43

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Quoin Pharmaceuticals

Ikarian Capital
Woodline Partners
Stonepine Capital Management
Standard Life Aberdeen
Boothbay Fund Management
ADAR1 Capital Management
AIGH Capital Management
Resolute Capital Asset Partners
Soleus Capital Management
Simplify Asset Management
Centiva Capital
GAMMA Investing
Rhumbline Advisers
UBS Group
SBI Securities

View all funds holding Quoin Pharmaceuticals